Semaglutide medication mimics your natural GLP-1, telling your body to release insulin, so your blood sugar may drop lower than usual, causing you to feel sluggish and tired
Integrated aesthetics: We offer services that complement your weight loss results, so you can look and feel your best at every stage of the journey
Higher-likelihood alternative causes: In UK clinical guidance, GSM is a common and under-treated driver of dryness, dyspareunia and tissue fragility, and should be actively assessed, particularly in peri-/post-menopausal patients or those with iatrogenic hypo-oestrogenism
The Lancet (2025): Once-weekly semaglutide 72 mg in adults with obesity (STEP UP): a randomised, controlled, phase 3b trial.EMC (2026): Wegovy 7.2 mg Solution for injection in pre-filled pen Patient Information Leaflet
Behavioral Integration: Habit Change to Complement the Medication Medication is only one piece of the weight-loss puzzle